Cargando…
Identification and Validation of Carbonic Anhydrase II as the First Target of the Anti-Inflammatory Drug Actarit
Background and purpose: Identifying the macromolecular targets of drug molecules is a fundamental aspect of drug discovery and pharmacology. Several drugs remain without known targets (orphan) despite large-scale in silico and in vitro target prediction efforts. Ligand-centric chemical-similarity-ba...
Autores principales: | Ghislat, Ghita, Rahman, Taufiq, Ballester, Pedro J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7699199/ https://www.ncbi.nlm.nih.gov/pubmed/33227945 http://dx.doi.org/10.3390/biom10111570 |
Ejemplares similares
-
Determination of Actarit from Human Plasma for Bioequivalence Studies
por: Loya, P., et al.
Publicado: (2010) -
Double-layered osmotic pump controlled release tablets of actarit: In vitro and in vivo evaluation
por: Li, Yuenan, et al.
Publicado: (2019) -
Predicting Cancer Drug Response In Vivo by Learning an Optimal Feature Selection of Tumour Molecular Profiles
por: Nguyen, Linh C., et al.
Publicado: (2021) -
Interpretable Machine Learning Models to Predict the Resistance of Breast Cancer Patients to Doxorubicin from Their microRNA Profiles
por: Ogunleye, Adeolu Z., et al.
Publicado: (2022) -
Anti-Carbonic Anhydrase II Antibodies in End-Stage Renal Disease Patients
por: Alver, Ahmet, et al.
Publicado: (2014)